US panel endorses Questcor's Acthar for infantile spasms
This article was originally published in Scrip
Executive Summary
Questcor Pharmaceuticals' HP Acthar Gel (repository corticotrophin injection) is effective and safe for the treatment of infantile spasms (IS), the US FDA's outside experts said on 6 May.